RE: DATA HUNTERS20 Dec 2021 15:28
Thanks for the link !
Apart from relevance to DIM and POLB, the article also gives some support for CF's contention of this area becoming a $ 250 billion market.....(OK, he may have got the detail wrong) :
.."Drug giants like AstraZeneca (AZN.L) are pouring $160 billion a year into unearthing new treatments. Artificial intelligence could provide a shortcut, by helping discover new treatments and getting them to market sooner..."
a number that is repeated later in the article :
.."The combined market value of Exscientia, Schrodinger (SDGR.O), Relay, Recursion, BenevolentAI and AbCellera Biologics (ABCL.O) is less than $16 billion, equivalent to just one-tenth of Big Pharma’s annual R&D costs. Given the potential benefits, it’s unlikely those companies will stay independent for long..."
All grist to the mill, IMO